VANCOUVER, British Columbia, May 11, 2026 (GLOBE NEWSWIRE) — Liberty Gold Corp. (TSX:LGD; OTCQX:LGDTF) (“Liberty Gold” or the “Company”), is pleased to announce its financial and operating results for the quarter ended March 31, 2026. All amounts are presented in United States dollars unless otherwise stated. FIRST QUARTER OF 2026 AND RECENT HIGHLIGHTS PROJECT HIGHLIGHTS – BLACK PINE During early 2026, Liberty Gold advanced the Black Pine Gold Project (“Black Pine” or the “Project”) through resource growth, continuation of a feasibility study, and key federal permitting milestones, while also executing strategic corporate initiatives.On April 3, 20261, we reported that the United States Forest Service published a Notice of Intent in the Federal Register to prepare an Environmental Impact Statement for Black Pine, initiating...

Successfully completed chronic toxicology studies for icovamenib, providing the nonclinical support for advancing to chronic clinical dosing, beyond the 12-week clinical dosing that has been used to date Topline data reported from the Phase II COVALENT-112 clinical trial of icovamenib in type 1 diabetes (“T1D”), supporting proposed mechanism of action First patients dosed in the Phase II COVALENT-211 and COVALENT-212 clinical trials of icovamenib in type 2 diabetes (“T2D”); both trials are on track with topline 26-week data expected in the fourth quarter of 2026 The Phase I GLP-131 (BMF-650) obesity clinical trial is on track; initial 28-day weight reduction data expected in the second quarter of 2026 Cash runway projected into the first quarter of 2027SAN CARLOS, Calif., May 11, 2026 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea”...

First Quarter 2026 Revenue of $22.7 millionAnnounces closing of acquisition of Monavate and Baanx OMAHA, Neb., May 11, 2026 (GLOBE NEWSWIRE) — Exodus Movement, Inc. (NYSE American: EXOD) (“Exodus”), a leading self-custodial cryptocurrency platform, today announced its unaudited results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Highlights (Unaudited)In USD millions, except percentages Q1 2026 Q1 2025 % ChangeRevenue $22.7 $36.0 (37%)Technology, development and user support 16.2 14.9 9%General and administrative 15.5 14.3 8%Loss on digital assets, net 36.4 28.8 (26%)Net loss $(32.1) $(12.9) (149%)Successful Closing of Monavate and Baanx AcquisitionOn May 1, 2026, Exodus announced the closing of the acquisition of the Monavate Holdings Limited (“Monavate”), Baanx US...

Completed transformative acquisition of PXL-770, (now SCY-770), an innovative, highly selective, direct AMPK activator for the treatment of autosomal dominant polycystic kidney disease (ADPKD)A Phase 2 proof-of-concept study of SCY-770 in ADPKD patients is anticipated to begin in Q4 2026 with an early efficacy readout anticipated in the second half of 2027Completed a private placement with net proceeds of approximately $37.2 million, after deducting placement agent fees and other transaction related expenses, with certain new and existing institutional and accredited investors. Approximately $24 million of the proceeds were received on March 31st with the balance received on April 1stSCYNEXIS announced dosing of the first patient using the intravenous (IV) formulation of SCY-247 in a Phase 1 study and plans to report topline data...

Pivotal Phase 2 with lasme-cel in r/r B-ALL (BALLI-01 trial) Pivotal Phase 2 first interim analysis expected in Q4 2026 BLA submission anticipated in 2028Phase 1 with eti-cel in r/r NHL (NATHALI-01 trial)Full Phase 1 dataset expected in Q4 2026InnovationPreclinical data on TALE-based epigenetic editing, a non-DNA cutting approach, to be presented at ASGCTServier (through Allogene): Interim pivotal data reported from the ALPHA3 trial of cema-cel (n=24)58.3% of patients in the cema-cel arm achieved MRD negativity versus 16.7% in the observation arm Favorable safety profile: no cases of CRS, ICANS, GvHD, or Treatment-Related Serious Adverse Events Study accrual expected to be completed by year-end 2027, interim EFS analysis in mid-2027, primary EFS analysis in mid-2028Cash, cash equivalents and fixed-term deposits of $188 million...

Cash and cash equivalents and restricted cash of $82.6 million as of March 31, 2026 — sufficient liquidity to execute across all three growth engines Completed the acquisition of Distributed Technologies Research (“DTR”) on April 30, 2026 in an all-stock transaction, integrating agentic AI and stablecoin payments infrastructure into the Bakkt platform Appointed Daniel Ishag as Chief Commercial Officer to lead the rebuild of Bakkt’s commercial organization across Bakkt Markets and Bakkt AgentATLANTA, May 11, 2026 (GLOBE NEWSWIRE) — Bakkt, Inc. (“Bakkt,” “Company,” “we” or “us”) (NYSE: BKKT) announced its financial and operational results for the quarter ended March 31, 2026 and provided an update on certain business developments. Management Commentary: “This quarter marks the beginning of a new chapter...

Full year fiscal 2026 revenue from continuing operations increased 9%; constant currency organic revenue growth was 7% Full year fiscal 2026 as reported diluted EPS from continuing operations increased to $7.93; adjusted EPS per diluted share increased to $10.17 Board approves new $1 billion share repurchase programDUBLIN, IRELAND, May 11, 2026 (GLOBE NEWSWIRE) — STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 fourth quarter and full year ended March 31, 2026. Total revenue from continuing operations for the fourth quarter of fiscal 2026 increased 7% to $1.6 billion compared with $1.5 billion in the fourth quarter of fiscal 2025. Constant currency organic revenue growth from continuing operations grew 5% in the fourth quarter. Revenue from continuing operations for the...

SALT LAKE CITY, May 11, 2026 (GLOBE NEWSWIRE) — Security National Financial Corporation (SNFC) (NASDAQ symbol “SNFCA”) announced financial results for the quarter ended March 31, 2026. For the three months ending March 31, 2026, SNFC’s after tax earnings increased over 9%, or approximately $587,000, from $6,414,000 in 2025 to $7,001,000 in 2026. Pre Tax earnings increased nearly 10%, or $802,000, to $9,052,000 (please see the table below). Scott M. Quist, President and Chief Executive Officer of SNFC, said, “To have an increase of over 9% in after tax earnings despite a top line decrease is a testament to the operational efficiencies our teams have been implementing over the last several years. Of course we are working diligently to also increase our top line, and that is a stated objective of all of our units.   Nevertheless,...

OMAHA, Neb. , May 11, 2026 (GLOBE NEWSWIRE) — Greystone Housing Impact Investors LP (NYSE: GHI) (the “Partnership”) announced financial results for the three months ended March 31, 2026. The Partnership also announced it will host a call on Tuesday, May 12th at 9:00 a.m. Eastern Time to discuss the results and its business outlook. Details for accessing the call can be found below under “Earnings Webcast & Conference Call.” Financial Highlights The Partnership reported the following results as of and for the three months ended March 31, 2026:Net income of $1.32 million or $0.01 per Beneficial Unit Certificate (“BUC”), basic and diluted Cash Available for Distribution (“CAD”) of $3.05 million or $0.13 per BUC Total assets of $1.49 billion Total Mortgage Revenue Bond (“MRB”) and Governmental Issuer Loan (“GIL”)...

BENBROOK, Texas, May 11, 2026 (GLOBE NEWSWIRE) — Tandy Leather Factory, Inc. (Nasdaq: TLF) today announced the Company’s financial results for the first fiscal quarter of 2026. Highlights from first quarter 2026:Revenues were $19.7 million, up 3.2% from 2025 Generated operating income of $0.4 million versus $0.3 million in 2025 Net income of $0.2 million versus $11.6 million in 2025 (from sale of headquarters) Gross margins of 61.0%, up from 56.3% in 2025 Operating expenses $11.6 million, up 11.2% from 2025 EBITDA from operations of 0.7 million Ended quarter with $10.1 million of cash and cash equivalentsTandy Leather Factory’s first quarter sales were $19.7 million in 2026, up from $19.0 million in 2025. First quarter 2026 gross profit was $12.0 million, up from $10.7 million in 2025. As of March 31, 2026, the Company held...